ERIS Lifesciences consolidated net profit declines 11.33% in the June 2022 quarter
Sales rise 14.08% to Rs 392.05 crore
Net profit of ERIS Lifesciences declined 11.33% to Rs 94.58 crore in the quarter ended June 2022 as against Rs 106.66 crore during the previous quarter ended June 2021. Sales rose 14.08% to Rs 392.05 crore in the quarter ended June 2022 as against Rs 343.66 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales392.05343.66 14 OPM %32.9536.81 -PBDT124.71131.60 -5 PBT101.27117.10 -14 NP94.58106.66 -11Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 05 2022 | 3:47 PM IST